Biophysical Journal
Volume 110, Issue 3, 2 February 2016, Pages 555-560
Journal home page for Biophysical Journal

Article
Automated Ex Situ Assays of Amyloid Formation on a Microfluidic Platform

https://doi.org/10.1016/j.bpj.2015.11.3523Get rights and content
Under a Creative Commons license
open access

Abstract

Increasingly prevalent neurodegenerative diseases are associated with the formation of nanoscale amyloid aggregates from normally soluble peptides and proteins. A widely used strategy for following the aggregation process and defining its kinetics involves the use of extrinsic dyes that undergo a spectral shift when bound to β-sheet-rich aggregates. An attractive route to carry out such studies is to perform ex situ assays, where the dye molecules are not present in the reaction mixture, but instead are only introduced into aliquots taken from the reaction at regular time intervals to avoid the possibility that the dye molecules interfere with the aggregation process. However, such ex situ measurements are time-consuming to perform, require large sample volumes, and do not provide for real-time observation of aggregation phenomena. To overcome these limitations, here we have designed and fabricated microfluidic devices that offer continuous and automated real-time ex situ tracking of the protein aggregation process. This device allows us to improve the time resolution of ex situ aggregation assays relative to conventional assays by more than one order of magnitude. The availability of an automated system for tracking the progress of protein aggregation reactions without the presence of marker molecules in the reaction mixtures opens up the possibility of routine noninvasive study of protein aggregation phenomena.

Cited by (0)

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Thomas Müller’s present address is Fluidic Analytics Ltd., Cambridge, United Kingdom.